Troglitazone's effect on lipoprotein(a) levels [6]

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 859-860

  Ovalle, Fernando ^a   Bell, David S H ^a,b  

^a University of Alabama at Birmingham   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; C PEPTIDE; LIPOPROTEIN; TROGLITAZONE;

ADULT; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG EFFECT; ETHNIC DIFFERENCE; FEMALE; HUMAN; LETTER; LIPOPROTEIN BLOOD LEVEL; MALE; TREATMENT OUTCOME; ULTRACENTRIFUGATION;

EID: 0032930211     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.859a     Document Type: Letter

References (3)

1. Matsumato K, Miyake S, Yano M, Veki Y, Tominaya Y: Increase of lipoprotein(a) with troglitazone. Lancet 350:1748-1749, 1997
2. Kulkarni KR, Garber DW, Marcovina SM, Segrest JP: Quantification of cholesterol in all lipoprotein classes by the YAP-II method. J Lipid Res 35:159-168, 1994
3. Stein JH, Rosenson RS: Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 157:1170-1176, 1997